CanniMed Therapeutics Inc. — Form D

CanniMed Therapeutics Inc. of SASKATOON, A9, a company, filed a Form D exempt-offering notice with the SEC on 2017-01-30. The offering totals $5.2M, of which $5.2M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (14)

NameRoleLocation
Doug BanzetDirectorSASKATOON, A9
Donald ChingDirectorSASKATOON, A9
Rob DuguidDirectorSASKATOON, A9
Marianne GreerDirectorSASKATOON, A9
Richard HoytDirectorSaskatoon, A9
John KnowlesDirectorSaskatoon, A9
DWAYNE LASHYNDirectorBETHESDA, MD
BRUCE MACKLERDirectorBETHESDA, MD
Brandon PriceDirectorPlantation, FL
Brenton ZettlDirectorSASKATOON, A9
Gulwant BajwaExecutive OfficerSASKATOON, A9
Larry HolbrookExecutive OfficerSaskatoon, A9
John KnowlesExecutive OfficerSaskatoon, A9
Brenton ZettlExecutive OfficerSASKATOON, A9

More